| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Vecuronium | Vecuronium EP Impurity B | VL4690001 | View CAS 50587-95-6 |
| Vecuronium | Vecuronium EP Impurity C | VE009801 | View CAS 73319-13-8 |
| Vecuronium | Vecuronium EP Impurity D (Bromide Salt) | VE009778 | View CAS 73319-30-9 |
| Catalogue No. | VL4690001 |
| CAS No. | 50587-95-6 |
| Molecular Formula | C35H60Br2N2O4 |
| Molecular Weight | 732.67 |
| Parent drug | Vecuronium |
| IUPAC Name | 1, 1'-((2S, 3S, 5S, 8R, 9S, 10S, 13S, 14S, 16S, 17R)-3, 17-diacetoxy-10, 13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-2, 16-diyl)bis(1-methylpiperidin-1-ium) |
| Synonyms | Vecuronium related compound B |
| References | Sci-Hub, Varenicline: A first-line treatment option for smoking cessation, 10.1016/j.clinthera.2009.03.021. (2022). Retrieved February 2, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1016/j.clinthera.2009.03.021 |
| Status | In-stock |
| ListName | Vecuronium EP Impurity B |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
